Table 1

Demographics data including laboratory and clinical parameters

Demographicsn=104
Age (years, mean±SD)60.66 (±13.50)
Sex (F) n (%)49 (47.12 %)
BMI* kg/m2 (mean±SD)32.14 (±7.80)
Comorbidities n (%)
 Hypertension46 (45.10%)
 Diabetes35 (34.65%)
 Lung Dx31 (30.69%)
 Heart Dx23 (22.55%)
 CKD15 (16.3%), 9 (9.78%) on HD
Race
 African-American53 (50.96%)
 Hispanic23 (22.12%)
 Caucasian9 (8.65%)
 Other4 (3.85%)
 Unknown15 (14.42%)
Smoking n (%)
 No51 (51.52%)
 Yes43 (43.43%)
Initial vitals
 Heart rate (mean±SD) bpm98.0 (±20.17)
 Respiratory rate (mean±SD) bts/min22.03 (±5.47)
 Temperature (mean±SD) °F99.4 (±2.18)
 Pulse oximetry (mean±SD) %89.9 (±10.09)
Laboratory abnormalities mean (±SD)
 Ferritin (ng/mL)1216.0 (±2790.6)
 CRP* (mg/dL)11.77 (±8.38)
 LDH* (U/L)452.06 (±292.36)
 D-dimer (ng/mL)5659.6 (±17267.49)
 Fibrinogen (mg/dL)490.23 (±178.44)
 Lymphocyte count (K/mm3)1.02 (±0.54)
 IL-6 (pg/mL)82.5 (±149.54)
 AST (U/L)56.8 (±74.90)
 ALT (U/L)38.6 (±31.93)
 Platelets (K/mm3)221.7 (±106.19)
 Triglycerides (mg/dL)186.7 (±253.78)
 BUN (mg/dL)28.4 (±24.07)
 Creatinine (mg/dL)2.61 (±3.95)
Treatments
 Remdesivir9 (9.68%)
 Sarilumab40 (39.22%)
 Anakinra12 (11.76%)
 Tocilizumab6 (5.88%)
 Etoposide1 (0.97%)
 IVIG19 (18.63%)
 Pulse steroids66 (64.71%)
 Hydroxychloroquine22 (21.57%)
 Azithromycin59 (57.2%)
 Antibiotics76 (73.08%)
  • ALT, alanine transaminase; AST, aspartate transaminase; bpm, beats per min; bts/min, breaths per min; BUN, blood urea nitrogen; CKD, chronic kidney disease; CRP, C reactive protein; Dx, diagnosis; F, Fahrenheit; HD, haemodialysis; IL-6, interleukin 6; IVIG, intravenous immunoglobulin; LDH, lactate dehydrogenase.